Regeneron Research Facility

New York, New York 10065

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Severe Hypertriglyceridemia (sHTG) Clinical Trial
Safety and Efficacy Following Repeat-Dose of Evinacumab (Anti-ANGPTL3) in Patients With Severe Hypertriglyceridemia (sHTG) at Risk for Acute Pancreatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Regeneron Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Lymphoma Clinical Trial
Study of REGN2810 and REGN1979 in Patients With Lymphoma
Status: Enrolling, Phase I
Updated: 12/31/1969
Regeneron Research Facility
mi
from
New York, NY
Click here to add this to my saved trials